Institutional investors hold a majority ownership of GILD through the 78.04% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended December 2016, these large investors purchased a net $2.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUNAMERICA ASSET MANAGEMENT LLC Bought 5.8 Million shares of Gilead Sciences
D. E. SHAW & CO. LP Bought 3.4 Million shares of Gilead Sciences
RENAISSANCE TECHNOLOGIES LLC Bought 3.3 Million shares of Gilead Sciences